Global Atherosclerosis Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Surgery;

Bypass Surgery (Coronary Artery Bypass Grafting (CABG)), Angioplasty, and Atherectomy.

By Therapy;

Atherosclerosis Medications, Cholesterol-lowering Medications, Antiplatelet drugs and Anticoagulants, Atherosclerosis Beta Blockers, and Others.

By Route of Administration;

Oral, Parenteral, and Others.

By Distribution Channel;

Hospital Pharmacies, Drug Stores, Retail Pharmacies, and Clinics.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn130215460 Published Date: November, 2024 Updated Date: December, 2024

Introduction

Global Atherosclerosis Market (USD Million), 2020 - 2030

In the year 2023, the Global Atherosclerosis Market was valued at USD 24,495.80 million. The size of this market is expected to increase to USD 33,290.76 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 4.5%.

Atherosclerosis, a chronic cardiovascular condition characterized by the accumulation of plaque within arterial walls, poses a significant global health challenge due to its association with heart disease, stroke, and other vascular complications. The global market for atherosclerosis encompasses a wide range of diagnostic and therapeutic interventions aimed at preventing, managing, and treating this progressive condition. With a growing prevalence of risk factors such as obesity, hypertension, diabetes, and sedentary lifestyles worldwide, the demand for innovative solutions to address atherosclerosis and its complications continues to rise.

There has been increasing recognition of the complex pathophysiology underlying atherosclerosis, driving advancements in diagnostic techniques and therapeutic strategies. Diagnostic modalities such as imaging studies, biomarker testing, and genetic screening play a crucial role in early detection, risk stratification, and monitoring of atherosclerotic disease progression. Additionally, lifestyle modifications, pharmacological interventions, and minimally invasive procedures are integral components of atherosclerosis management, aimed at reducing cardiovascular risk factors, stabilizing plaque, and preventing acute cardiovascular events. The global market for atherosclerosis encompasses a diverse array of stakeholders, including pharmaceutical companies, medical device manufacturers, healthcare providers, and research institutions, collaborating to develop innovative solutions and improve patient outcomes in the fight against cardiovascular disease.

As the burden of atherosclerosis continues to escalate globally, fueled by aging populations, urbanization, and changes in dietary and lifestyle habits, the market for atherosclerosis is expected to witness significant growth in the coming years. With ongoing research efforts focused on unraveling the molecular mechanisms of atherosclerosis, identifying novel therapeutic targets, and developing personalized treatment approaches, the landscape of atherosclerosis management is poised for transformation. Moreover, initiatives aimed at raising awareness, promoting preventive healthcare measures, and optimizing healthcare delivery systems are crucial for mitigating the socioeconomic burden of atherosclerosis and improving cardiovascular health outcomes on a global scale.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Surgery
    2. Market Snapshot, By Therapy
    3. Market Snapshot, By Route of Administration
    4. Market Snapshot, By Distribution Channel
    5. Market Snapshot, By Region
  4. Global Atherosclerosis Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Aging Population
        2. Sedentary Lifestyle
        3. High Cholesterol Levels
        4. Smoking
      2. Restraints
        1. Stringent Regulatory Requirements
        2. Limited Efficacy of Current Treatments
        3. High Treatment Costs
        4. Adverse Effects of Medications
      3. Opportunities
        1. Technological Advancements
        2. Emerging Markets
        3. Personalized Medicine
        4. Novel Therapeutic Targets
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Atherosclerosis Market, By Surgery, 2020 - 2030 (USD Million)
      1. Bypass Surgery (Coronary Artery Bypass Grafting (CABG))
      2. Angioplasty
      3. Atherectomy
    2. Global Atherosclerosis Market, By Therapy, 2020 - 2030 (USD Million)
      1. Atherosclerosis Medications
      2. Cholesterol-lowering Medications
      3. Antiplatelet drugs and Anticoagulants
      4. Atherosclerosis Beta Blockers
      5. Others
    3. Global Atherosclerosis Market, By Route of Administration, 2020 - 2030 (USD Million)
      1. Oral
      2. Parenteral
      3. Others
    4. Global Atherosclerosis Market, By Distribution Channel, 2020 - 2030 (USD Million)
      1. Hospital Pharmacies
      2. Drug Stores
      3. Retail Pharmacies
      4. Clinics
    5. Global Atherosclerosis Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. GlaxoSmithKline
      2. Merck
      3. F. Hoffmann-La Roche Ltd
      4. Pharmaceuticals
      5. Anthera Pharmaceuticals
      6. Novartis AG
      7. Sanofi
      8. Johnson
      9. Johnson
  7. Analyst View
  8. Future Outlook of the Market